P. M. Hooymans

1.4k total citations
35 papers, 875 citations indexed

About

P. M. Hooymans is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Genetics. According to data from OpenAlex, P. M. Hooymans has authored 35 papers receiving a total of 875 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Public Health, Environmental and Occupational Health, 10 papers in Pediatrics, Perinatology and Child Health and 6 papers in Genetics. Recurrent topics in P. M. Hooymans's work include Acute Lymphoblastic Leukemia research (20 papers), Pregnancy and Medication Impact (8 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). P. M. Hooymans is often cited by papers focused on Acute Lymphoblastic Leukemia research (20 papers), Pregnancy and Medication Impact (8 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). P. M. Hooymans collaborates with scholars based in Netherlands, United States and Poland. P. M. Hooymans's co-authors include Luc J. J. Derijks, Lennard P. L. Gilissen, L.G.J.B. Engels, Daniël W. Hommes, Dennis R. Wong, Paul Bus, L.P. Bos, Dirk J. de Jong, Chris J. Mulder and Sander J. H. van Deventer and has published in prestigious journals such as Gastroenterology, The American Journal of Cardiology and Clinical Chemistry.

In The Last Decade

P. M. Hooymans

34 papers receiving 852 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. M. Hooymans Netherlands 15 536 398 214 123 111 35 875
Dennis R. Wong Netherlands 15 393 0.7× 338 0.8× 187 0.9× 80 0.7× 73 0.7× 41 786
C P Willoughby United Kingdom 12 341 0.6× 558 1.4× 359 1.7× 27 0.2× 6 0.1× 23 963
Joanna Pawłowska Poland 18 84 0.2× 100 0.3× 464 2.2× 350 2.8× 20 0.2× 121 1.9k
L. Laursen Denmark 17 102 0.2× 274 0.7× 195 0.9× 97 0.8× 5 0.0× 43 1.1k
Alf S. Alving United States 18 483 0.9× 155 0.4× 63 0.3× 624 5.1× 133 1.2× 26 1.5k
Gourdas Choudhuri India 24 115 0.2× 208 0.5× 614 2.9× 15 0.1× 29 0.3× 82 1.7k
Juan Ignacio Arenas Spain 18 32 0.1× 246 0.6× 637 3.0× 22 0.2× 31 0.3× 44 1.2k
Naoko Miwa Japan 13 181 0.3× 32 0.1× 76 0.4× 89 0.7× 55 0.5× 33 755
Ling Mei China 10 59 0.1× 159 0.4× 168 0.8× 10 0.1× 25 0.2× 34 558
Jörg Jahnel Austria 15 21 0.0× 85 0.2× 435 2.0× 76 0.6× 79 0.7× 30 983

Countries citing papers authored by P. M. Hooymans

Since Specialization
Citations

This map shows the geographic impact of P. M. Hooymans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. M. Hooymans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. M. Hooymans more than expected).

Fields of papers citing papers by P. M. Hooymans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. M. Hooymans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. M. Hooymans. The network helps show where P. M. Hooymans may publish in the future.

Co-authorship network of co-authors of P. M. Hooymans

This figure shows the co-authorship network connecting the top 25 collaborators of P. M. Hooymans. A scholar is included among the top collaborators of P. M. Hooymans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. M. Hooymans. P. M. Hooymans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marrewijk, Corine van, Dirk de Jong, Hans Scheffer, et al.. (2019). Genotype-Guided Thiopurine Dosing Does not Lead to Additional Costs in Patients With Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 13(7). 838–845. 23 indexed citations
2.
Coenen, Marieke J. H., Corine J. van Marrewijk, Geert Wanten, et al.. (2017). More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing. Inflammatory Bowel Diseases. 23(10). 1873–1881. 25 indexed citations
3.
Meurs, Marjan van, et al.. (2016). Azathioprine Therapy in a Pediatric TPMT-Deficient Patient—Still an Option. Therapeutic Drug Monitoring. 39(1). 1–4. 3 indexed citations
4.
Wong, Dennis R., Marieke J. H. Coenen, Sita H. Vermeulen, et al.. (2016). Early Assessment of Thiopurine Metabolites Identifies Patients at Risk of Thiopurine-induced Leukopenia in Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 11(2). 175–184. 47 indexed citations
5.
Coenen, Marieke J. H., Barbara Franke, Luc J. J. Derijks, et al.. (2015). Sa1249 Azathioprine and 6-Mercaptopurine Are Equally Effective in Thiopurine Naïve IBD Patients. Gastroenterology. 148(4). S–269. 1 indexed citations
6.
Gilissen, Lennard P. L., Dennis R. Wong, L.G.J.B. Engels, et al.. (2012). Therapeutic drug monitoring of thiopurine metabolites in adult thiopurine tolerant IBD patients on maintenance therapy. Journal of Crohn s and Colitis. 6(6). 698–707. 56 indexed citations
7.
Wong, Dennis R., et al.. (2007). The Role of Xanthine Oxidase in Thiopurine Metabolism: A Case Report. Therapeutic Drug Monitoring. 29(6). 845–848. 33 indexed citations
8.
Boer, Nanne K.H. de, Luc J. J. Derijks, W. Ruitenbeek, et al.. (2007). Extended Thiopurine Metabolite Assessment During 6‐Thioguanine Therapy for Immunomodulation in Crohn's Disease. The Journal of Clinical Pharmacology. 47(2). 187–191. 13 indexed citations
9.
Boer, Nanne K.H. de, Dennis R. Wong, Bindia Jharap, et al.. (2007). Dose-Dependent Influence of 5-Aminosalicylates on Thiopurine Metabolism. The American Journal of Gastroenterology. 102(12). 2747–2753. 84 indexed citations
10.
Gilissen, Lennard P. L., Luc J. J. Derijks, Jörgen Bierau, et al.. (2006). Pancytopenia due to high 6-methylmercaptopurine levels in a 6-mercaptopurine treated patient with Crohn's disease. Digestive and Liver Disease. 39(2). 182–186. 19 indexed citations
11.
Derijks, Luc J. J., Lennard P. L. Gilissen, P. M. Hooymans, & Daniël W. Hommes. (2006). Review article: thiopurines in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 24(5). 715–729. 124 indexed citations
12.
Derijks, Luc J. J., Dirk J. de Jong, L.G.J.B. Engels, et al.. (2003). 6-Thioguanine seems promising in azathioprine- or 6-mercaptopurine-intolerant inflammatory bowel disease patients. European Journal of Gastroenterology & Hepatology. 15(1). 63–67. 56 indexed citations
13.
Konijnenberg, Mark, et al.. (2000). PROCEEDINGS OF THE DUTCH SOCIETY FOR CLINICALPHARMACOLOGY AND BIOPHARMACY. British Journal of Clinical Pharmacology. 49(4). 383–396. 1 indexed citations
14.
Hooymans, P. M., et al.. (1997). Falsification of Thai dianabol.. Pharmacy World & Science. 19(4). 208–209. 6 indexed citations
15.
Hooymans, P. M., et al.. (1991). Comparison of Steady-State Serum Concentrations of Digoxin in Tablets (Lanoxin) and Capsules (Lanoxicaps) in the Elderly. DICP. 25(10). 1043–1046. 2 indexed citations
16.
McElnay, James C. & P. M. Hooymans. (1985). Renal disease and digoxin immunoassays.. BMJ. 291(6505). 1319–1319. 3 indexed citations
17.
Hooymans, P. M., et al.. (1985). Effect of heparin on digitoxin protein binding. Clinical Pharmacology & Therapeutics. 37(1). 55–60. 6 indexed citations
18.
Hooymans, P. M., et al.. (1984). Factors Affecting the Determination of Unbound Carbamazepine Concentrations in Plasma. Pharmaceutical Research. 1(1). 49–49. 2 indexed citations
19.
Janknegt, R., et al.. (1983). Do evacuated blood collection tubes interfere with therapeutic drug monitoring?. Pharmacy World & Science. 5(6). 287–290. 8 indexed citations
20.
Hooymans, P. M. & F.W.H.M. Merkus. (1979). The mechanism of the interaction between digoxin and quinidine. Pharmacy World & Science. 1(1). 212–216. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dennis R. Wong Breakdown of academic impact, for papers by C P Willoughby Breakdown of academic impact, for papers by Joanna Pawłowska Breakdown of academic impact, for papers by L. Laursen Breakdown of academic impact, for papers by Alf S. Alving Breakdown of academic impact, for papers by Gourdas Choudhuri Breakdown of academic impact, for papers by Juan Ignacio Arenas Breakdown of academic impact, for papers by Naoko Miwa Breakdown of academic impact, for papers by Ling Mei Breakdown of academic impact, for papers by Jörg Jahnel
Rankless by CCL
2026